210 related articles for article (PubMed ID: 31379559)
1. Pioglitazone Reduces β Amyloid Levels
Quan Q; Qian Y; Li X; Li M
Front Aging Neurosci; 2019; 11():178. PubMed ID: 31379559
[TBL] [Abstract][Full Text] [Related]
2. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model.
Quan Q; Ma X; Li M; Li X; Yuan H
Exp Ther Med; 2024 Jan; 27(1):31. PubMed ID: 38125359
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.
Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC
Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376
[TBL] [Abstract][Full Text] [Related]
6. Tripchlorolide Attenuates β-amyloid Generation via Suppressing PPARγ-Regulated BACE1 Activity in N2a/APP695 Cells.
Lin N; Chen LM; Pan XD; Zhu YG; Zhang J; Shi YQ; Chen XC
Mol Neurobiol; 2016 Nov; 53(9):6397-6406. PubMed ID: 26582466
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.
Wang X; Wang Y; Hu JP; Yu S; Li BK; Cui Y; Ren L; Zhang LD
Mol Neurobiol; 2017 May; 54(4):2939-2949. PubMed ID: 27023226
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells.
Cao G; Su P; Zhang S; Guo L; Zhang H; Liang Y; Qin C; Zhang W
Eur J Pharmacol; 2016 Dec; 793():101-108. PubMed ID: 27840193
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhiza uralensis and Semilicoisoflavone B Reduce Aβ Secretion by Increasing PPARγ Expression and Inhibiting STAT3 Phosphorylation to Inhibit BACE1 Expression.
Gu MY; Chun YS; Zhao D; Ryu SY; Yang HO
Mol Nutr Food Res; 2018 Mar; 62(6):e1700633. PubMed ID: 29143445
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin Gallate Attenuates β-Amyloid Generation and Oxidative Stress Involvement of PPARγ in N2a/APP695 Cells.
Zhang ZX; Li YB; Zhao RP
Neurochem Res; 2017 Feb; 42(2):468-480. PubMed ID: 27889855
[TBL] [Abstract][Full Text] [Related]
11. Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer's Disease Model Mice Targeting Beta-Amyloid Production.
Yan L; Deng Y; Gao J; Liu Y; Li F; Shi J; Gong Q
Front Pharmacol; 2017; 8():106. PubMed ID: 28337142
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.
Quan Q; Wang J; Li X; Wang Y
PLoS One; 2013; 8(3):e59155. PubMed ID: 23520555
[TBL] [Abstract][Full Text] [Related]
13. Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons.
Liu F; Wang Y; Yan M; Zhang L; Pang T; Liao H
Neurosci Lett; 2013 Dec; 557 Pt B():90-4. PubMed ID: 24184877
[TBL] [Abstract][Full Text] [Related]
14. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
15. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
16. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.
Stern AL; Ghura S; Gannon PJ; Akay-Espinoza C; Phan JM; Yee AC; Vassar R; Gelman BB; Kolson DL; Jordan-Sciutto KL
J Neurosci; 2018 May; 38(18):4288-4300. PubMed ID: 29632166
[TBL] [Abstract][Full Text] [Related]
17. PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model.
Katsouri L; Lim YM; Blondrath K; Eleftheriadou I; Lombardero L; Birch AM; Mirzaei N; Irvine EE; Mazarakis ND; Sastre M
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12292-12297. PubMed ID: 27791018
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
[TBL] [Abstract][Full Text] [Related]
19. Icariside II Ameliorates Cognitive Impairments Induced by Chronic Cerebral Hypoperfusion by Inhibiting the Amyloidogenic Pathway: Involvement of BDNF/TrkB/CREB Signaling and Up-Regulation of PPARα and PPARγ in Rats.
Yin C; Deng Y; Liu Y; Gao J; Yan L; Gong Q
Front Pharmacol; 2018; 9():1211. PubMed ID: 30405422
[TBL] [Abstract][Full Text] [Related]
20. PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice.
Toba J; Nikkuni M; Ishizeki M; Yoshii A; Watamura N; Inoue T; Ohshima T
Biochem Biophys Res Commun; 2016 May; 473(4):1039-1044. PubMed ID: 27059136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
